Regeneron Pharmaceuticals, Inc.
REGNNasdaqCIK 872589HealthcareFiscal year ends Dec 31
Reports and events: 327 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2023-06-1416:07 ET | 8-K | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001104659-23-071187 |
| 2023-05-0407:14 ET | 10-Q | Quarterly reportPeriod 2023-03-31 | 0001804220-23-000016 |
| 2023-05-0407:11 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001804220-23-000015 |
| 2023-04-2116:01 ET | DEF 14A | Proxy statement | 0001308179-23-000728 |
| 2023-04-1707:37 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001104659-23-045897 |
| 2023-04-1007:01 ET | 8-K | 2.02 Results of operations | 0001104659-23-043287 |
| 2023-03-2916:01 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001104659-23-038299 |
| 2023-02-0609:23 ET | 10-K | Annual reportPeriod 2022-12-31 | 0001804220-23-000008 |
| 2023-02-0307:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001804220-23-000005 |
| 2023-01-0908:49 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-23-002091 |
| 2022-12-2016:01 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001104659-22-128613 |
| 2022-11-0307:25 ET | 10-Q | Quarterly reportPeriod 2022-09-30 | 0001804220-22-000031 |
| 2022-11-0307:19 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001804220-22-000029 |
| 2022-10-0307:17 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001104659-22-104901 |
| 2022-08-0307:21 ET | 10-Q | Quarterly reportPeriod 2022-06-30 | 0001804220-22-000023 |
| 2022-08-0307:08 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001804220-22-000020 |
| 2022-06-1516:11 ET | 8-K | 5.07 Shareholder vote results | 0001104659-22-071446 |
| 2022-06-0207:36 ET | 8-K | 1.01 Entry into a material agreement | 0001104659-22-067375 |
| 2022-05-0407:17 ET | 10-Q | Quarterly reportPeriod 2022-03-31 | 0001804220-22-000015 |
| 2022-05-0407:08 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001804220-22-000013 |
| 2022-04-2116:09 ET | DEF 14A | Proxy statementPeriod 2022-06-10 | 0000930413-22-000787 |
| 2022-03-0806:15 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001104659-22-031232 |
| 2022-02-0709:25 ET | 10-K | Annual reportPeriod 2021-12-31 | 0001804220-22-000007 |
| 2022-02-0407:29 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001804220-22-000004 |
| 2022-01-1006:02 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-22-002403 |
| 2021-11-0407:19 ET | 10-Q | Quarterly reportPeriod 2021-09-30 | 0001804220-21-000033 |
| 2021-11-0407:12 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001804220-21-000031 |
| 2021-09-1616:01 ET | 8-K | 1.01 Entry into a material agreement | 0001104659-21-116352 |
| 2021-08-0507:11 ET | 10-Q | Quarterly reportPeriod 2021-06-30 | 0001804220-21-000025 |
| 2021-08-0506:59 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001804220-21-000023 |
| 2021-06-1616:36 ET | 8-K | 5.07 Shareholder vote results | 0001104659-21-082035 |
| 2021-05-0607:21 ET | 10-Q | Quarterly reportPeriod 2021-03-31 | 0001804220-21-000017 |
| 2021-05-0607:12 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001804220-21-000015 |
| 2021-04-2316:11 ET | DEF 14A | Proxy statementPeriod 2021-06-11 | 0000930413-21-000869 |
| 2021-02-0809:13 ET | 10-K | Annual reportPeriod 2020-12-31 | 0001804220-21-000008 |
| 2021-02-0507:34 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001804220-21-000006 |
| 2021-01-1516:01 ET | 8-K | 1.01 Entry into a material agreement | 0001104659-21-004699 |
| 2021-01-1106:03 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-21-002614 |
| 2021-01-0506:03 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001104659-21-000538 |
| 2020-11-0507:48 ET | 10-Q | Quarterly reportPeriod 2020-09-30 | 0001804220-20-000030 |
| 2020-11-0507:32 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001804220-20-000028 |
| 2020-08-1906:00 ET | 8-K | 1.01 Entry into a material agreement | 0001104659-20-096661 |
| 2020-08-1216:32 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-20-093924 |
| 2020-08-0507:36 ET | 10-Q | Quarterly reportPeriod 2020-06-30 | 0001804220-20-000022 |
| 2020-08-0507:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001804220-20-000020 |
| 2020-07-0707:28 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure | 0001104659-20-081559 |
| 2020-06-1717:10 ET | SC 13D/A | Ownership report, active investor, amended | 0001140361-20-014084 |
| 2020-06-1616:33 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001104659-20-073794 |
| 2020-05-2916:15 ET | SC 13D/A | Ownership report, active investor, amended | 0001140361-20-012717 |
| 2020-05-2916:07 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-20-067752 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 6, 2026, 16:27 ET. Listed shows no prices and gives no investment advice.